30 related articles for article (PubMed ID: 3028701)
1. Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
Lancaster SG; Todd PA
Drugs; 1988 Jun; 35(6):646-69. PubMed ID: 2844497
[TBL] [Abstract][Full Text] [Related]
2. The effect of saturation of ACE binding sites on the pharmacokinetics of enalaprilat in man.
Wade JR; Meredith PA; Hughes DM; Elliott HL
Br J Clin Pharmacol; 1992 Feb; 33(2):155-60. PubMed ID: 1312853
[TBL] [Abstract][Full Text] [Related]
3. Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers.
Hansen EF; Bendtsen F; Henriksen JH
Pharmacol Toxicol; 1999 Mar; 84(3):110-4. PubMed ID: 10193670
[TBL] [Abstract][Full Text] [Related]
4. A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans.
Kawamura M; Imanishi M; Matsushima Y; Akabane S; Kuramochi M; Ito K; Omae T
Jpn J Pharmacol; 1990 Oct; 54(2):143-9. PubMed ID: 1963909
[TBL] [Abstract][Full Text] [Related]
5. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure.
Dickstein K; Aarsland T; Woie L; Abrahamsen AM; Fyhrquist F; Cummings S; Gomex HJ; Hagen E; Kristianson K
Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850
[TBL] [Abstract][Full Text] [Related]
6. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
Woie L; Dickstein K; Kaada B
Gen Pharmacol; 1987; 18(6):577-87. PubMed ID: 2822521
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
Nussberger J; Wuerzner G; Jensen C; Brunner HR
Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
[TBL] [Abstract][Full Text] [Related]
8. Lack of angiotensin I accumulation after converting enzyme blockade by enalapril or lisinopril in man.
Nussberger J; Brunner DB; Waeber B; Biollaz J; Brunner HR
Clin Sci (Lond); 1987 Mar; 72(3):387-9. PubMed ID: 3028701
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of angiotensin converting enzyme inhibitors. A review.
Nelson EB; Pool JL; Taylor AA
Am J Med; 1986 Oct; 81(4C):13-8. PubMed ID: 3022580
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors and glycosuria.
Milavetz JJ; Popovtzer MM
Arch Intern Med; 1992 May; 152(5):1081-3. PubMed ID: 1316108
[TBL] [Abstract][Full Text] [Related]
11. The clinical pharmacology of lisinopril.
Case DE
J Hum Hypertens; 1989 Jun; 3 Suppl 1():127-31. PubMed ID: 2550635
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
